Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
InfuSystem Holdings ( (INFU) ) has shared an announcement.
On December 10, 2025, InfuSystem Holdings announced that the Centers for Medicare and Medicaid Services (CMS) has included two of its electronic infusion pumps in the list of qualifying products for separate payment under the NOPAIN Act, effective January 1, 2026. This decision is part of CMS’s broader strategy to combat the opioid crisis by promoting non-opioid pain management alternatives, potentially boosting InfuSystem’s Pain Management business by encouraging healthcare providers to adopt these non-opioid treatments.
The most recent analyst rating on (INFU) stock is a Hold with a $9.50 price target. To see the full list of analyst forecasts on InfuSystem Holdings stock, see the INFU Stock Forecast page.
Spark’s Take on INFU Stock
According to Spark, TipRanks’ AI Analyst, INFU is a Neutral.
InfuSystem Holdings’ strong financial performance and strategic initiatives in Oncology and Wound Care are significant positives. However, the stock’s technical indicators suggest bearish momentum, and its high P/E ratio indicates potential overvaluation. The earnings call provided a positive outlook, but challenges in certain revenue segments remain.
To see Spark’s full report on INFU stock, click here.
More about InfuSystem Holdings
InfuSystem Holdings, Inc. is a leading national healthcare service provider headquartered in Rochester Hills, Michigan. The company facilitates outpatient care for durable medical equipment manufacturers and healthcare providers through a two-platform model: Patient Services and Device Solutions. The Patient Services segment includes Oncology, Pain Management, and Wound Therapy businesses, while Device Solutions focuses on direct payer rentals, pump and consumable sales, and biomedical services and repair.
Average Trading Volume: 193,818
Technical Sentiment Signal: Buy
Current Market Cap: $177.9M
Find detailed analytics on INFU stock on TipRanks’ Stock Analysis page.